Portfolio
HBM Healthcare Investments holds and manages a well-balanced portfolio with high value-creation potential.
Overview as at 31 December 2025
Currency allocation of assets
Emphasis on US dollar investments
56
340
US dollar (USD)
59
Euro (EUR)
20
Renminbi (CNY)
10
Indian rupee (INR)
5
Swiss franc (CHF)
3
Other currencies (CAD, DKK, GBP, HDK, SEK)
3
#8aacb4
#3e395b
#ebbe1a
#a00f3b
#52755e
#8c74af
#00a4c8
#dc6c3f
#cab415
#423e3d
Allocation of assets
Mainly invested in private companies or in companies originating
from the private companies portfolio.
62
340
Private companies
32
Public (from private) companies
21
Public companies
30
Funds
8
Cash and cash equivalents
6
Other assets
3
#8aacb4
#3e395b
#ebbe1a
#a00f3b
#52755e
#8c74af
#00a4c8
#dc6c3f
#cab415
#423e3d
Development phase of portfolio companies
Mainly invested in revenue generating companies or in companies with products at an advanced stage of development.
69
90
Profitable
49
Products on the market
14
Phase I
8
Phase II
14
Phase III
14
Preclinical
1
#8aacb4
#3e395b
#ebbe1a
#a00f3b
#52755e
#8c74af
#00a4c8
#dc6c3f
#cab415
#423e3d
Therapeutic area of the lead product of portfolio companies
Broadly diversified areas of activity.
79
350
Others
35
Oncology
17
Synthetic biology
11
Central nervous system
10
Immunology/Inflammation
10
Orphan diseases
10
Digital Health
4
Medical technology / diagnostics
3
#8aacb4
#3e395b
#ebbe1a
#a00f3b
#52755e
#8c74af
#00a4c8
#dc6c3f
#cab415
#423e3d